Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Claudin 7 Antikörper (pTyr210)

CLDN7 Reaktivität: Human, Maus, Ratte WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN6281344
  • Target Alle Claudin 7 (CLDN7) Antikörper anzeigen
    Claudin 7 (CLDN7)
    Bindungsspezifität
    • 15
    • 14
    • 9
    • 7
    • 7
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 140-220, pTyr210
    Reaktivität
    • 62
    • 21
    • 20
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    Human, Maus, Ratte
    Wirt
    • 59
    • 3
    Kaninchen
    Klonalität
    • 59
    • 3
    Polyklonal
    Konjugat
    • 31
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser Claudin 7 Antikörper ist unkonjugiert
    Applikation
    • 36
    • 30
    • 25
    • 15
    • 13
    • 13
    • 13
    • 5
    • 3
    • 3
    • 2
    • 2
    Western Blotting (WB), ELISA
    Verwendungszweck
    Rabbit polyclonal to Phospho-Claudin-7 (Y210).
    Spezifität
    Phospho-Claudin-7 (Y210) Polyclonal Antibody detects endogenous levels of Claudin-7 protein only when phosphorylated at Y210.
    Aufreinigung
    The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
    Immunogen
    Synthesized peptide derived from human Claudin-7 around the phosphorylation site of Y210.
    Isotyp
    IgG
    Top Product
    Discover our top product CLDN7 Primärantikörper
  • Applikationshinweise
    WB 1:500-1:2000
    ELISA 1:5000
    Kommentare

    Expressed in kidney, lung and prostate. Isoform 1 seems to be predominant, except in some normal prostate samples, where isoform 2 is the major form. Down-regulated in breast cancers, including ductal carcinoma in situ (DCIS), lobular carcinoma in situ (LCIS) and invasive ductal carcinoma (IDC) (at protein level), as well as in several cancer cell lines. Loss of expression correlates with histological grade, occurring predominantly in high-grade lesions.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    1 mg/mL
    Buffer
    Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Store at -20°C, and avoid repeat freeze-thaw cycles.
  • Target
    Claudin 7 (CLDN7)
    Andere Bezeichnung
    Claudin-7 (CLDN7 Produkte)
    Synonyme
    cb388 antikoerper, claudin7 antikoerper, cldn7 antikoerper, wu:fd19f08 antikoerper, MGC53400 antikoerper, MGC75689 antikoerper, CLDN7 antikoerper, CEPTRL2 antikoerper, CLDN-7 antikoerper, CPETRL2 antikoerper, Hs.84359 antikoerper, claudin-1 antikoerper, claudin 7b antikoerper, claudin 7 L homeolog antikoerper, claudin 7 antikoerper, cldn7b antikoerper, cldn7.L antikoerper, cldn7 antikoerper, CLDN7 antikoerper, Cldn7 antikoerper
    Molekulargewicht
    32 kDa
    Gen-ID
    1366
    UniProt
    O95471
    Pathways
    Hepatitis C
Sie sind hier:
Kundenservice